Your browser doesn't support javascript.
loading
The newly engineered monoclonal antibody ON104, targeting the oxidized Macrophage Migration Inhibitory Factor (oxMIF), ameliorates clinical and histopathological signs of collagen-induced arthritis.
Ferhat, Maroua; Mangano, Katia; Mirkina, Irina; Mayer, Julia; Rossmueller, Gregor; Schinagl, Alexander; Kerschbaumer, Randolf; Nicoletti, Ferdinando; Thiele, Michael; Landlinger, Christine.
Afiliación
  • Ferhat M; OncoOne Research & Development GmbH, Vienna, Austria.
  • Mangano K; University of Catania, Department of Biomedical and Biotechnological Sciences, Catania, Italy.
  • Mirkina I; OncoOne Research & Development GmbH, Vienna, Austria.
  • Mayer J; OncoOne Research & Development GmbH, Vienna, Austria.
  • Rossmueller G; OncoOne Research & Development GmbH, Vienna, Austria.
  • Schinagl A; OncoOne Research & Development GmbH, Vienna, Austria.
  • Kerschbaumer R; OncoOne Research & Development GmbH, Vienna, Austria.
  • Nicoletti F; University of Catania, Department of Biomedical and Biotechnological Sciences, Catania, Italy.
  • Thiele M; OncoOne Research & Development GmbH, Vienna, Austria. Electronic address: michael.thiele@oncoone.com.
  • Landlinger C; OncoOne Research & Development GmbH, Vienna, Austria.
Eur J Pharmacol ; 956: 175997, 2023 Oct 05.
Article en En | MEDLINE | ID: mdl-37579967
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Experimental / Artritis Reumatoide / Factores Inhibidores de la Migración de Macrófagos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Experimental / Artritis Reumatoide / Factores Inhibidores de la Migración de Macrófagos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article